Brief: Sirtex Medical And Grand Pharmaceutical Group Limited Receive NDA Approval Of Sir-Spheres Y-90 Resin Microspheres In China
09/02/2022 14:00
Feb 9 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK :
* SIRTEX MEDICAL AND GRAND PHARMACEUTICAL GROUP LIMITED
RECEIVE
NDA APPROVAL OF SIR-SPHERES® Y-90 RESIN MICROSPHERES IN CHINA
FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Source text for Eikon: ID:nCNW1rgJRa
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement